10 mg glipizide ingestion: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving 10 mg glipizide ingestion

• Role of KATP Channel Loss in Type 2 Diabetes
  NCT06830096 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations

Common questions

How many recruiting trials involve 10 mg glipizide ingestion?

1 recruiting trial across 3 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.